Cargando…

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study

OBJECTIVE: The molecular classification system of endometrial carcinoma (EC) in ‘The Cancer Genome Atlas’ is widely acknowledged for its prognostic utility. Subsequently, more simplified classification system that incorporate DNA polymerase epsilon (POLE) exonuclease domain mutations, mismatch repai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shuangni, Sun, Zezheng, Zong, Liju, Yan, Jie, Yu, Mei, Chen, Jie, Lu, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024187/ https://www.ncbi.nlm.nih.gov/pubmed/35320887 http://dx.doi.org/10.3802/jgo.2022.33.e38

Ejemplares similares

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas
por: Zong, Liju, et al.
Publicado: (2023)

Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay
por: Yu, Shuangni, et al.
Publicado: (2019)

A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms
por: Chen, Xianlong, et al.
Publicado: (2022)

Phenotype of POLE-mutated endometrial cancer
por: Imboden, Sara, et al.
Publicado: (2019)

Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis
por: He, Ya, et al.
Publicado: (2020)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene
por: Hino, Hitoshi, et al.
Publicado: (2019)

The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis
por: Jumaah, Alaa Salah, et al.
Publicado: (2022)

Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma
por: Mao, Xinxin, et al.
Publicado: (2021)

Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia
por: Cheng, Hongyan, et al.
Publicado: (2023)

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
por: Church, David N., et al.
Publicado: (2014)

The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
por: Wu, Qing, et al.
Publicado: (2022)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

POLE proofreading mutation, immune response and prognosis in endometrial cancer
por: van Gool, Inge C., et al.
Publicado: (2015)

POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma
por: Li, Yiran, et al.
Publicado: (2020)

Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
por: Zong, Liju, et al.
Publicado: (2020)

POLE exonuclease domain mutations in endometrial carcinoma: a case report
por: Pasciuto, Maria Paola, et al.
Publicado: (2023)

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
por: Kim, Gilhyang, et al.
Publicado: (2021)

Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability
por: Haruma, Tomoko, et al.
Publicado: (2018)

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2021)

VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
por: Zong, Liju, et al.
Publicado: (2019)

Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma
por: Cui, Ran, et al.
Publicado: (2017)

Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation
por: Wang, Tieyan, et al.
Publicado: (2023)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis
por: Jumaah, Alaa Salah, et al.
Publicado: (2020)

Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region
por: Siraj, Abdul K., et al.
Publicado: (2019)

Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
por: Saeki, Harumi, et al.
Publicado: (2023)

Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential Analysis
por: Gu, Yu, et al.
Publicado: (2021)

Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers
por: Garmezy, Benjamin, et al.
Publicado: (2022)

Evaluation of HER2/neu Expression in High-Grade Endometrial Carcinoma and Its Clinicopathological Correlation
por: Sarmadi, Soheila, et al.
Publicado: (2019)

Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma
por: Zhang, Li, et al.
Publicado: (2018)

Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation
por: Yan, Jie, et al.
Publicado: (2020)

Ezrin promotes invasion and metastasis of pancreatic cancer cells
por: Meng, Yunxiao, et al.
Publicado: (2010)

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

Carcinoma of the lower female genital tract in patients with genitourinary malformations: a clinicopathologic analysis of 36 cases
por: Zong, Liju, et al.
Publicado: (2019)

Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations
por: Hatakeyama, Keiichi, et al.
Publicado: (2018)

Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study
por: Ma, Xiao, et al.
Publicado: (2023)

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines
por: Loukovaara, Mikko, et al.
Publicado: (2022)

Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer
por: Zhang, Jie, et al.
Publicado: (2022)

First description of ultramutated endometrial cancer caused by germline loss-of-function and somatic exonuclease domain mutations in POLE gene
por: Rosa, Reginaldo Cruz Alves, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vkamqqn0nilsvkhofs5i0v4bgo